Carcinoembryonic antigen (CEA) levels were determined in 742 postoperative patients with breast cancer. Within this group the percentage of elevated (24.0 ng/ml) assays increased with UICC clinical stage and was 14.8% (12/81), 23.7% (27/114), 73.1% (190/260) and 20.0% (49/245) for stages I, 11, 111,
Carcinoembryonic antigen in hepatocellular cancer
β Scribed by Macnab, G M; Urbanowicz, J M; Kew, M C
- Book ID
- 109833746
- Publisher
- Nature Publishing Group
- Year
- 1978
- Tongue
- English
- Weight
- 608 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0007-0920
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We studied the immunoreactivity by immunohistology of two carcinoembryonic antigens (CEA) with specific and two CEA antibodies with nonspecific cross-reacting antigen (NCA) cross reactivity (CEA/ NCA) in 180 primary breast carcinomas. Positive tissue staining was found in more than 90% of the specim
We present findings on plasma CEA in relatives and spouses from six kindreds manifesting the Cancer Family syndrome. The CEA distributions per se were transformed to square root CEA to correct for skewness and kurtosis. Significant effects of age and duration of smoking were adjusted for by linear r
## Abstract Carcinoembryonic antigen (CEA, ceacam5) is an important tumorβassociated antigen with reported roles, __e.g.__, in immunological defense, cell adhesion, cell survival and metastasis. Its overexpression in cancer cells is known to involve transcriptional activation of the CEA gene, but t